Meeting Banner
Abstract #2813

7T MRS of neurometabolites and associations with cognitive deficits in mild cognitive impairment

Georg Oeltzschner1,2, S. Andrea Wijtenburg3, Mark Mikkelsen1,2, Richard A. E. Edden1,2, Peter B. Barker1,2, Jin Hui Joo4, Jeannie-Marie S. Leoutsakos4, Laura M. Rowland3, Clifford I. Workman4, and Gwenn S. Smith1,4

1Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States, 2F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, United States, 3Neuroimaging Research Program, Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, United States, 4Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, United States

Mild cognitive impairment (MCI) is associated with increased risk of developing Alzheimer’s Disease (AD). Here, levels of multiple brain metabolites in healthy controls and MCI patients using 7T magnetic resonance spectroscopy in the anterior (ACC) and posterior (PCC) cingulate cortex were studied. MCI patients showed decreased GABA/tCr (ACC, PCC), Glu/tCr (PCC), NAA/tCr (PCC), and increased mI/tCr (ACC). Worse episodic verbal memory performance correlated with lower Glu/tCr (PCC), lower NAA/tCr (PCC), and higher mI/tCr (ACC, PCC). Worse verbal fluency performance correlated with lower GSH/tCr (PCC). In summary, MCI is associated with decreased GABA and glutamate, most consistently in the PCC.

This abstract and the presentation materials are available to members only; a login is required.

Join Here